Charles River is pleased to participate in the scientific program of the Biomarkers Series UK, where more than 450 global pharma, biotech, and academic leaders, come together to discuss opportunities and challenges in biomarker research, from precision medicine and companion diagnostics to digital biomarkers and clinical trials.
Visit our multidisciplinary team of experts in booth 33 to learn how we can support your therapeutic development from discovery screening through translation to the clinic with a wide range of biomarker services to include identification, validation, analysis and design of custom biomarker solutions.
Don’t miss our scientific presentation and poster:
Thursday, February 20, 9:30 a.m.
Stream 1 - Biomarkers in Drug Discovery & Development – Therapeutic Areas: Neuroscience, Cardiovascular Disorders and Rare Disease
Determining Correct Biomarkers for Drug Development
Dr. Tuulia Huhtala, Head of Biomarkers and Molecular Imaging, CNS Discovery, will discuss how to evaluate biomarkers for different therapeutic areas and organ systems throughout the entire drug development process.
Tools for Identifying and Monitoring PD Immune Biomarkers from Preclinical Through to Clinical Stages of Drug Discovery | Russell Garland
For more information or to schedule a meeting at Biomarker Congress, please contact us at [email protected].
Meet Fios Genomics
Fios Genomics will be attending the Biomarkers Series UK, visit them at booth 11. Through our new partnership with Fios Genomics, a leader in bioinformatics and analysis, clients now have expert analytical support for the microarrays, next generation sequencing (NGS), proteomics, metabolomics, epigenetics, and associated metadata to keep their projects moving forward.
Join us on day 1 as Dr. Adrian Carr, Bioinformatics Team Leader, will be speaking at 2:10 pm, in stream 1: Biomarkers in Drug Discovery & Development – Therapeutic Areas: Oncology and Immunology